Blue Cross and Blue Shield of Minnesota and Blue Plus ...

www.bluecrossmn.com

Jan 31, 2022 · Intravitreal Angiogenesis Inhibitors for Treatment of Retinal and Choroidal Vascular Conditions (Beovu™, Eylea®, Lucentis®, Macugen®) J0178, J0179, J2503, J2778 . II-216 ; Laronidase (Aldurazyme®) J1931 II-249 . Lisocabtagene Maraleucel (Breyanzi®) J3490, J3590, J9999, Q2054 .

  Conditions, Vascular, Inhibitors, Intravitreal, Angiogenesis, Choroidal, Intravitreal angiogenesis inhibitors, Choroidal vascular conditions